SavedAdd your journal

Journals / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 2

Accuracy of Transcutaneous Bilirubin Measurement from Unexposed Skin with a New Generation Device in Neonates Receiving Phototherapy

Murat Elevli
Emel Ataoglu
Iren Yoruk
Demet Oguz
Pages
113–119
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study shows that TCB measurements made from unexposed areas can be safely measured in patients with PT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Transcutaneous bilirubin (TCB) measurement methods cause false results during and after phototherapy (PT), so bilirubin levels are followed by total serum bilirubin (TSB) measurement, which causes taking blood samples and increases the risk of infection.
📊
Key Findings & Data:Methods: This study was conducted between 01 February-30 June 2020 as a single-center cross-sectional study.
💡
Conclusion & Impact:Conclusion: This study shows that TCB measurements made from unexposed areas can be safely measured in patients with PT.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Transcutaneous bilirubin (TCB) measurement methods cause false results during and after phototherapy (PT), so bilirubin levels are followed by total serum bilirubin (TSB) measurement, which causes taking blood samples and increases the risk of infection. We compared the TCB measurements made with Bilicare™ and TSB measurements by preventing PT exposure of a part of the skin in newborns receiving PT and evaluating the reliability of the measurements made with Bilicare™ after PT. Methods: This study was conducted between 01 February-30 June 2020 as a single-center cross-sectional study. The study included newborns aged 35 weeks and up who were admitted to a neonatal intensive care unit for PT. TSB measurements were reviewed by the hospital automation system. Bilicare™ bilirubin meter was used for TCB measurements. Simultaneous TSB and TCB measurements were made before PT. The skin area to be measured was covered with a radio-opaque patch. After PT, simultaneous TSB, exposed skin area TCB, and patched skin area TCB were measured. Simultaneous TSB and TCB measurements were repeated 24 h after the end of PT. The relationship between these data was evaluated statistically. Results: This study was conducted with 171 late preterm and term newborns with a gestational age of ≥35 weeks. 79 (46.1%) were female and 92 (53.9%) were male newborns. The mean gestational age was 38.3±1.15 weeks. When maternal and newborn blood groups were evaluated, 107 (62.5%) had no blood incompatibility, 53 (30.9%) had ABO incompatibility incompatibility, 9 (5.2%) had Rh incompatibility, 1 (0.6%) had subgroup incompatibility, and 1 (0.6%) had ABO incompatibility and Rh incompatibility. The correlation coefficient (r) of TSB and TCB measurements made before PT was 0.97 and a strong correlation was found. A correlation coefficient (r) of 0.98 and a strong correlation between closed skin area TCB measurement and TSB measurement immediately after PT were detected. The correlation coefficient (r) was 0.96 and a strong correlation was found between the TCB and TSB measurements performed 24 h after the PT was terminated. Conclusion: This study shows that TCB measurements made from unexposed areas can be safely measured in patients with PT.

🔖

Cite This Article

Elevli, M., Ataoglu, E., Yoruk, I., Oguz, D. (2022). Accuracy of Transcutaneous Bilirubin Measurement from Unexposed Skin with a New Generation Device in Neonates Receiving Phototherapy. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 2, 113–119. https://ajindex.com/articles/534963

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004;113:775-80
  2. Khan DS, Mirza A, Bhatti A, Shabbir A, Tariq B, Rizvi A. Effectiveness of Transcutaneous Bilirubin Measurement in High-Risk Neonates and to Evaluate Validity of Transcutaneous Bilirubin With Total Serum Bilirubin Levels in Both Low and High-Risk Neonates at a Tertiary Care Center in a Developing Country. Cureus 2021;13:e13685
  3. Kuboi T, Kusaka T, Kawada K, et al. Hour-specific nomogram for transcutaneous bilirubin in Japanese neonates. Pediatr Int 2013;55:608-11
  4. Yadav A, Yadav GAM, Mala M. Diagnostic accuracy of transcutaneous bilirubinometer as non invasive method to measure bilirubin in neonates. Al Ameen J Med Sci 2021;14:200-5
  5. Canocha Lucanova L, Zibolenova J, Matasova K, Docekalova L, Zibolen M. Accuracy of enhanced transcutaneous bilirubinometry according to various measurement sites. Turk Arch Pediatr 2021;56:15-21
  6. American Academy of Pediatrics Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316
  7. Çoban A, Türkmen MK, Gürsoy T. Türk Neonatoloji Derneği yenidoğan sarılıklarında yaklaşım,izlem ve tedavi rehberi. Turk Pediatri Ars 2018;53(Suppl 1):172-9
  8. Ho SR, Lin YC, Chen CN. The Impact of phototherapy on the accuracy of transcutaneous bilirubin measurements in neonates: Optimal Measurement Site and Timing. Diagnostics (Basel) 2021;11:1729
  9. Wainer S, Rabi Y, Parmar SM, Allegro D, Lyon M. Impact of skin tone on the performance of a transcutaneous jaundice meter. Acta Paediatr 2009;98:1909-15
  10. Kitsommart R, Yangthara B, Wutthigate P, Paes B. Accuracy of transcutaneous bilirubin measured by the BiliCare device in late preterm and term neonates. J Matern Fetal Neonatal Med 2016;29:3641-5
  11. Pratesi S, Boni L, Tofani L, Berti E, Sollai S, Dani C. Comparison of the transcutaneous bilirubinometers BiliCare and Minolta JM-103 in late preterm and term neonates. J Matern Fetal Neonatal Med 2016;29:3014-8
  12. Chokemungmeepisarn P, Tantiprabha W, Kosarat S, Manopunya S. Accuracy of the BilicareTM transcutaneous bilirubinometer as the predischarge screening tool for significant hyperbilirubinemia in healthy term and late preterm neonates. J Matern Fetal Neonatal Med 2020;33:57- 61
  13. Costa-Posada U, Concheiro-Guisán A, Táboas- Ledo MF, et al. Accuracy of transcutaneous bilirub